- Home
- AIIR vs CERT Comparison
AIIR vs CERT Comparison
Compare AIIR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIIR | CERT |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AIIR | CERT |
|---|---|---|
| Price | $7.80 | $7.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 8.3K | ★ 2.1M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $5.29 | $4.45 |
| 52 Week High | $8.97 | $13.88 |
Technical Indicators
Market Signals| Indicator | AIIR | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 38.50 |
| Support Level | $6.63 | $6.48 |
| Resistance Level | $8.59 | $7.44 |
| Average True Range (ATR) | 0.89 | 0.30 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 47.33 | 4.93 |
Price Performance
Historical ComparisonAbout AIIR Air Global PLC Ordinary Shares
AIR Global PLC operates in the social inhalation products sector and has operations across multiple international markets. Its portfolio includes businesses and products related to shisha and hookah, including flavored shisha molasses, hookah and shisha e-commerce platforms, and charcoal-free shisha devices. The company also conducts product research and testing in partnership with independent laboratories to support the development of inhalation-related products and technologies.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.